🇺🇸 FDA
Patent

US 6727227

Tetrapetide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application

expired A61KA61K38/00A61P

Quick answer

US patent 6727227 (Tetrapetide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application) held by Obschestvo S Ogranichennoi Otvetstven-Nostiju “Klinika Instituta {overscore (B)}ioregulyatsii Gerontologii” expires Mon Apr 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Obschestvo S Ogranichennoi Otvetstven-Nostiju “Klinika Instituta {overscore (B)}ioregulyatsii Gerontologii”
Grant date
Tue Apr 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61P, A61P1/00, A61P11/00